APO-DIGOXIN DIN 02281201
Health Canada record
| Active ingredient(s) | DIGOXIN 0.25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01AA05 DIGOXIN |
| Original market date | 22-Jun-2006 |
| Current status date | 04-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIGOXIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02554399 | AURO-DIGOXIN | AURO PHARMA INC | Tablet | DIGOXIN 0.0625 MG | Marketed |
| 02554402 | AURO-DIGOXIN | AURO PHARMA INC | Tablet | DIGOXIN 0.125 MG | Marketed |
| 02048264 | DIGOXIN INJECTION C.S.D. | SANDOZ CANADA INCORPORATED | Liquid | DIGOXIN 0.5 MG | Marketed |
| 02498502 | JAMP DIGOXIN | JAMP PHARMA CORPORATION | Tablet | DIGOXIN 0.0625 MG | Marketed |
| 02498529 | JAMP DIGOXIN | JAMP PHARMA CORPORATION | Tablet | DIGOXIN 0.25 MG | Approved |
| 02498510 | JAMP DIGOXIN | JAMP PHARMA CORPORATION | Tablet | DIGOXIN 0.125 MG | Marketed |
| 02335700 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.0625 MG | Marketed |
| 02242320 | PMS-DIGOXIN | PHARMASCIENCE INC | Solution | DIGOXIN 0.05 MG | Marketed |
| 02335719 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.125 MG | Marketed |
| 02281236 | APO-DIGOXIN | APOTEX INC | Tablet | DIGOXIN 0.0625 MG | Dormant |
| 02281228 | APO-DIGOXIN | APOTEX INC | Tablet | DIGOXIN 0.125 MG | Dormant |
| 02242321 | LANOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.0625 MG | Cancelled Post Market |
| 02242322 | LANOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.125 MG | Cancelled Post Market |
| 02242323 | LANOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.25 MG | Cancelled Post Market |
| 02048272 | PEDIATRIC DIGOXIN INJECTION C.S.D. | SANDOZ CANADA INCORPORATED | Liquid | DIGOXIN 0.05 MG | Cancelled Post Market |
| 02335727 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.25 MG | Dormant |
| 02245428 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.25 MG | Cancelled Post Market |
| 02518422 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.25 MG | Cancelled Pre Market |
| 02518392 | PMS-DIGOXIN | PHARMASCIENCE INC | Solution | DIGOXIN 0.05 MG | Cancelled Pre Market |
| 02518406 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.0625 MG | Cancelled Pre Market |
| 02518414 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.125 MG | Cancelled Pre Market |
| 02245426 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.0625 MG | Cancelled Post Market |
| 02245427 | PMS-DIGOXIN | PHARMASCIENCE INC | Tablet | DIGOXIN 0.125 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 8018 | 2006-06-12 | Abbreviated New Drug Submission (ANDS) |
International API supply for DIGOXIN
3 valid EDQM Certificates of Suitability from 3 holders. 3 active FDA Drug Master Files.
Request a quote for APO-DIGOXIN